Not available outside of the UK & Ireland.
Application
Trioxsalen has been used: to induce small deletion mutations in worms in combination with ultraviolet A (UVA) to induce interstrand crosslinks (ICLs) in DNA for the preparation and photoactivation of trimethyl psoralen
Trioxsalen has been used for mutagenesis of N2 worms4,5.
Biochem/physiol Actions
Photochemical crosslinker of DNA that has been used as a probe for nucleic acid structure and function. Trioxsalen has also been used to crosslink DNA onto mica surfaces.
Trioxsalen (TRX) is a 4,5′,8-trimethylated psoralen analog, which belongs to the family of furocoumarins. It is mostly used to treat psoriasis.
Features and Benefits
This compound was developed by Valeant. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
This compound is a featured product for Apoptosis research. Click here to discover more featured Apoptosis products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.
Packaging
1 g in glass bottle
100, 500 mg in glass bottle
Preparation Note
Trioxsalen is soluble in chloroform at 50 mg/ml and yields a clear, colorless to faint yellow solution.
This product has met the following criteria to qualify for the following awards: